Biotage AB Nomination Committee

A Nomination Committee consisting of shareholder representatives and the
Chairman of the Board of Directors has been formed for Biotage AB. The
Nomination Committee shall, before the Annual General Meeting 2014, prepare
proposals for the election of Chairman and other members of the Board of
Directors, the election of Chairman of the Annual General Meeting, election of
Auditors, the determination of fees and matters pertaining thereto.

The members of the Nomination Committee are:

Anders Walldov, Brohuvudet AB and direct holding

Jesper Bonnevier, Länsförsäkringar Fonder

Tommy Jacobsson, Varenne AB

Ove Mattsson, Chairman of the Board

Shareholders wishing to submit a proposal for members of the Board of Directors
may do so by sending e-mail to the Chairman of the Board of Directors of Biotage
AB at: info@biotage.com



Biotage discloses the information provided herein pursuant to the Swedish
Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The
information was submitted for publication at 14.00 on 26 September 2013.

Contact:
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84, torben.jorgensen@biotage.com

About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical
chemistry, medicinal chemistry, separation and purification. The customers
include pharmaceutical and biotech companies, companies within the food industry
and leading academic institutes. The company is headquartered in Uppsala and has
offices in the US, UK, China and Japan. Biotage has approx. 290 employees and
had sales of 463 MSEK in 2012. Biotage is listed on the NASDAQ OMX Nordic
Stockholm stock exchange. Website: www.biotage.com